Table 2

Individual patient results for oxLDL, EPCs and coronary response to ACh

Patient NooxLDL (IU)EPCs (µL blood)% Change in diameter (10−4 M ACh)
136.340.2672−1.6140
270.330.0142−18.2796
349.390−34.1583
4100.890.335114.1741
582.650.3233−0.2766
672.660.4110−14.7591
765.921.1996−2.1605
872.080.55673.3432
956.380.2376−8.6903
1056.06ND−6.1734
1144.220.4284−1.6225
1242.870.4909−2.3068
1338.770−37.7922
1453.550.2537−47.2260
1523.360.0480−37.0728
1642.52ND−8.5830
1720.01ND−17.5202
1836.220−14.9939
1941.86ND−12.1033
2034.640.0976−19.6740
21NS0.0505−26.7600
2248.350.50883.7042
2342.25ND−3.9413
2436.81016.5367
2529.260−19.0864
2629.330ND
2741.920.0788−11.3369
2841.010−3.9623
2941.730.0266−14.1770
3026.31NDND
3133.99ND−1.5818
32NSND−9.2091
3350.650−39.1786
  • ACh, acetylcholine; EPCs, endothelial progenitor cells; ND, not determined; NS, no sample; oxLDL, oxidised low-density lipoprotein.